ArticleIndian journal of endocrinology and metabolism
Efficacy of Dapagliflozin vs. Saroglitazar on Hepatic Steatosis and Fibrosis in Patients of Type 2 Diabetes Mellitus and Metabolic-Associated Steatotic Liver Disease (MASLD).
Bijay K Das et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.